<DOC>
	<DOCNO>NCT00404001</DOCNO>
	<brief_summary>The primary objective study evaluate safety MD-0727 patient primary hypercholesterolemia determine low density lipoprotein cholesterol ( LDL-C ) lower effect dose-response MD-0727 patient primary hypercholesterolemia .</brief_summary>
	<brief_title>Study Oral MD-0727 Administered Patients With Primary Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Patient male nonpregnant , nonbreastfeeding female , least 18 year age Patient must agree use contraception and/or birth control sexually active Patient may lipidlowering therapy least 6 week prior study must fast LDLC 130 mg/dl great Screening Patient must average two fast LDLC measure great than/equal 130 mg/dl less than/equal 210 mg/dl difference two measure less than/equal 15 % . Patient may fast serum triglyceride less 300 mg/dl Pretreatment Period Patient 's BMI must great than/equal 18.5 less 35.0 Screening Patient must complete physical exam , 12lead ECG , laboratory test ( include pregnancy test ) clinicallysignificant finding prior first dose study medication Patient agree comply TLC diet Patient complete 6week washout previous lipidlowering medication include overthecounter product Patient medical condition prohibit per protocol condition Investigator believe may limit patient 's ability participate study Patient TSH level &gt; 1.5 X upper limit normal Patient history cardiovascular coronary artery disease , uncontrolled endocrine metabolic disease know influence serum lipid lipoprotein , patient history NYHA Class III IV congestive heart failure Patient diabetic present fast blood glucose great than/equal 126 mg/dl time prior randomization Patient uncontrolled hypertension systolic blood pressure great than/equal 180 mm Hg diastolic blood pressure great than/equal 110 mmg Hg two study visit prior first dose study medication Patient 10year CHD risk &gt; 20 % Patient ALT AST &gt; 1.5 X upper limit normal prior randomization Patient history alcohol drug abuse within 12 month Screening Patient use prohibit medication ( per protocol ) 14day Pretreatment Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Microbia</keyword>
	<keyword>MD-0727</keyword>
	<keyword>Primary Hypercholesterolemia</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>LDL</keyword>
</DOC>